CORDIS - EU research results
CORDIS

EuPRAXIA Preparatory Phase Project

Objective

EuPRAXIA is a distributed, compact and innovative accelerator facility based on plasma technology. It has been selected for the 2021 Update of the ESFRI Roadmap. In its first phase, its consortium of 51 institutes and industry partners will construct an electron-beam-driven plasma accelerator in the metropolitan area of Rome, thus bringing innovation, potential for spin-off companies, state-of-the art scientific applications and a vibrant international user community to the middle of Italy. In its second phase, EuPRAXIA will build one laser-driven plasma accelerator at a site to be chosen between several options in Europe.

EuPRAXIA will serve users in ultra-fast science, e.g. on high-resolution medical imaging, deeply penetrating positron annihilation spectroscopy for materials and with Europe’s most southern free-electron laser (FEL). It will offer fascinating capabilities for research on biomolecules, viruses and microscopic processes. EuPRAXIA will thus be a transformative step in the development of ultra-compact accelerators and applications. The Preparatory Phase project EuPRAXIA-PP will prepare its full implementation.

Coordinator

ISTITUTO NAZIONALE DI FISICA NUCLEARE
Net EU contribution
€ 552 500,00
Address
Via Enrico Fermi 54
00044 Frascati
Italy

See on map

Region
Centro (IT) Lazio Roma
Activity type
Research Organisations
Links
Total cost
€ 552 500,00

Participants (24)

Partners (9)